<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04555174</url>
  </required_header>
  <id_info>
    <org_study_id>C1902</org_study_id>
    <nct_id>NCT04555174</nct_id>
  </id_info>
  <brief_title>BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry</brief_title>
  <acronym>BIOFLOW-VIII</acronym>
  <official_title>BIOTRONIK - SaFety and Performance Registry for an aLl-comers Subject Population With the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: BIOFLOW-VIII</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotronik France</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Biotronik AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BIOFLOW-VIII registry is a post-market clinical evaluation of the Orsiro Mission stent in&#xD;
      subjects requiring coronary revascularization with Drug Eluting Stents (DES).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BIOFLOW-VIII is a national, prospective, non-randomized, multi-center, open-label registry to&#xD;
      confirm both, the acute performance as well as the mid- and long-term safety and clinical&#xD;
      performance of the Orsiro Mission stent in an all-comers patient population within daily&#xD;
      clinical practice.&#xD;
&#xD;
      A total of 868 subjects will be enrolled at approximately 50 study sites in France. Clinical&#xD;
      follow-ups will take place at 6, 12, 36 and 60 months post index-procedure. Follow-ups can be&#xD;
      conducted by telephone.&#xD;
&#xD;
      A subgroup analysis will evaluate the outcomes for patients treated ambulatory with same day&#xD;
      discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2020</start_date>
  <completion_date type="Anticipated">March 2027</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Rate of Target Lesion Failure (TLF) at 12 months follow-up</measure>
    <time_frame>12 months</time_frame>
    <description>TLF according to Academic Research Consortium-2 (ARC-2) definition: Composite of Cardiac Death, target-vessel Myocardial Infarction and clinically-driven Target Lesion Revascularization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Target Lesion Failure (TLF) at 6, 36 and 60 months follow-up</measure>
    <time_frame>6, 36, and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Target Vessel Revascularization (TVR) at 6, 12, 36, and 60 months follow-up</measure>
    <time_frame>6, 12, 36, and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Target Lesion Revascularization (TLR) at 6, 12, 36, and 60 months follow-up</measure>
    <time_frame>6, 12, 36, and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Definite Stent Thrombosis at 6, 12, 36, and 60 months follow-up</measure>
    <time_frame>6, 12, 36, and 60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of participants with Clinical Device Success defined as attainment of &lt; 30% residual stenosis of the target lesion using Orsiro Mission only</measure>
    <time_frame>Immediately after the intervention/procedure/surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of participants with Clinical Procedural Success defined as attainment of &lt; 30% residual stenosis of the target lesion using any percutaneous method without occurrence of in-hospital death, myocardial infarction or target lesion revascularization</measure>
    <time_frame>From the intervention/procedure/surgery until hospital discharge, assessed up to 3 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">868</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Orsiro Mission DES</arm_group_label>
    <description>All subjects will be implanted with the Limus Eluting Orsiro Mission Stent System and followed up until 60 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orsiro Mission DES</intervention_name>
    <description>Percutaneous Coronary Intervention (PCI)</description>
    <arm_group_label>Orsiro Mission DES</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Orsiro Mission is indicated for improving coronary luminal diameter in patients with&#xD;
        symptomatic ischemic heart disease due to discrete de-novo stenotic lesions and in-stent&#xD;
        restenotic lesions (length ≤ 40 mm) in the native coronary arteries with a reference vessel&#xD;
        diameter of 2.25 mm to 4.0 mm.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic coronary artery disease intended to be treated with an Orsiro Mission DES&#xD;
             (silent ischemia is permitted)&#xD;
&#xD;
          -  Subject has signed informed consent for data release&#xD;
&#xD;
          -  Subject is geographically stable and willing to participate at all follow up&#xD;
             assessments&#xD;
&#xD;
          -  Subject is ≥ 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject did not sign informed consent for data release&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Known allergy (which cannot be pre-treated) to all types of P2Y12 inhibitor&#xD;
             (Clopidogrel, Ticagrelor, Prasugrel, Ticlopidine and Cangrelor; thus preventing the&#xD;
             use of the appropriate P2Y12 inhibitor), aspirin, both heparin and bivalirudin, L-605&#xD;
             cobalt- chromium (Co-Cr) alloy or one of its major elements (cobalt, chromium,&#xD;
             tungsten, nickel), silicon carbide, PLLA, mTOR inhibiting drugs such as sirolimus, or&#xD;
             contrast media&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Barragan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Polyclinique les Fleurs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathrin Meinhardt, MSc</last_name>
    <phone>+41754427453</phone>
    <email>kathrin.meinhardt@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mathilde Violland</last_name>
    <phone>+33789831147</phone>
    <email>mathilde.violland@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique Esquirol Saint Hilaire</name>
      <address>
        <city>Agen</city>
        <zip>47002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrice Colin, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Axium</name>
      <address>
        <city>Aix-En-Provence</city>
        <zip>13090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Antibes</name>
      <address>
        <city>Antibes</city>
        <zip>06600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Bellemain-Appaix, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Bastia</name>
      <address>
        <city>Bastia</city>
        <zip>20604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ziad Boueri, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GCS de cardiologie</name>
      <address>
        <city>Bayonne</city>
        <zip>64109</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de Bois Bernard</name>
      <address>
        <city>Bois-Bernard</city>
        <zip>62320</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Khaled Chairat, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Convert</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>1000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Saint Martin</name>
      <address>
        <city>Caen</city>
        <zip>14050</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Tours</name>
      <address>
        <city>Chambray-lès-Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CHU de Cermont Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CH Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Majid Boukantar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH d'Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67504</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de La Rochelle</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CHU Félix Guyon</name>
      <address>
        <city>La Réunion</city>
        <zip>97400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérôme Corré, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Sainte Clotilde</name>
      <address>
        <city>La Réunion</city>
        <zip>97490</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe Pouillot, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis Pasteur</name>
      <address>
        <city>Le Coudray</city>
        <zip>28630</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de l'Estuaire</name>
      <address>
        <city>Le Havre</city>
        <zip>76620</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Marie Lannelongue</name>
      <address>
        <city>Le Plessis Robinson</city>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH de Metz</name>
      <address>
        <city>Metz</city>
        <zip>57038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthieu Valla, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Pont de Chaume</name>
      <address>
        <city>Montauban</city>
        <zip>82000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique du Millénaire</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique du Diaconat</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Shayne, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé du Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Ambroise Paré</name>
      <address>
        <city>Neuilly-Sur-Seine</city>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique Les Fleurs</name>
      <address>
        <city>Ollioules</city>
        <zip>83192</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefane Manzo-Silberman, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75674</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CH de Pau</name>
      <address>
        <city>Pau</city>
        <zip>64046</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique La Croix du Sud</name>
      <address>
        <city>Quint-Fonsegrives</city>
        <zip>31130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique Saint Laurent</name>
      <address>
        <city>Rennes</city>
        <zip>35700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Clinique Rhéna / GERC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nouvel Hopital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH de Toulon</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH de Tourcoing</name>
      <address>
        <city>Tourcoing</city>
        <zip>59200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Decoulx, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nouvelle Clinique de Tours Plus</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc-Antoine Arnould, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Joseph</name>
      <address>
        <city>Trélazé</city>
        <zip>49800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique Vauban</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>CH de Vannes</name>
      <address>
        <city>Vannes</city>
        <zip>56017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Médpôle Lyon Villeurbanne</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Staat, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de cardiologie d'Evecquemont</name>
      <address>
        <city>Évecquemont</city>
        <zip>78740</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ryad Bourkaib, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 2, 2020</study_first_submitted>
  <study_first_submitted_qc>September 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Observational registry</keyword>
  <keyword>All-comers open-label registry</keyword>
  <keyword>Percutaneous Coronary Intervention (PCI)</keyword>
  <keyword>Coronary revascularization</keyword>
  <keyword>Orsiro Mission Drug Eluting Stent (DES)</keyword>
  <keyword>Stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The primary outcome data will be shared after publication of it.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

